[ad_1]
Mylan N.V. (NASDAQ: MYL) at this time introduced that its U.S.-based Mylan Institutional LLC enterprise is conducting a voluntary nationwide recall to the patron stage of 1 lot of Daptomycin for Injection, 500 mg/vial because of the presence of particulate matter present in one single-dose vial manufactured b
[ad_2]
Source link
